The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

H.E. Mubaraka Ibrahim, CIO and chief AI officer of Emirates Health Services, says the country is building an AI governance model that pairs clinical innovation with policy, training and prevention-focused population health.

The Philadelphia health system has committed to returning 10 million hours back to patient care over the next three years using AI, says Dr. Baligh Yehia, president of Jefferson Health.

Eitan Okun, head of the Paul Feder Laboratory for Alzheimer's Disease Research at Bar-Ilan University, discusses the lab's study on the mechanistic link between pregnancy with a Down syndrome fetus and an elevated risk of maternal cognitive decline.

According to Nasser Massoud, Concept Realisation's founder and managing director, public-private partnerships in the MENA region let companies access data needed to create effective, scalable digital health tools.

CMS says about 25% of the spend is fraudulent or being abused by providers, says Carol Howard, vice president of innovation and adoption at Janus Health.

For the year ahead, we'll be watching for precision medicine advances, cybersecurity challenges, policy shifts and, of course, continued evolution of AI-enabled care delivery, say the editors of the HIMSS Media brands.